# A quantitative process evaluation of a feasibility randomised controlled trial of a co‐designed cognitive behavioural therapy intervention for people with type 1 diabetes and disordered eating (steady trial): Auditing treatment integrity and delivery

**Authors:** Amy Harrison, Natalie Zaremba, Jennie Brown, Divina Pillay, Jacqueline Allan, Rachael Tan, Janet Treasure, Khalida Ismail, Marietta Stadler

PMC · DOI: 10.1111/dme.70124 · Diabetic Medicine · 2025-09-12

## TL;DR

This study evaluates a psychological treatment for people with type 1 diabetes and disordered eating to ensure it can be effectively scaled up for future trials.

## Contribution

The study provides a detailed process evaluation of a co-designed CBT intervention for type 1 diabetes and disordered eating.

## Key findings

- The five most used tools in the STEADY intervention were CBT formulation, behavioral experiments, thought records, goal setting, and understanding emotions.
- Therapists demonstrated competent adherence to CBT with a mean CTS-R score of 3.81.
- The average time to complete the STEADY intervention was 153.3 days.

## Abstract

Safe management of people with Type 1 diabetes and Eating Disorders study (STEADY), a complex psychological intervention, defined by the Medical Research Council as involving multiple interacting components and individualised delivery, is a treatment designed for people with Type 1 diabetes and mild‐to‐moderate disordered eating (T1DE) which integrates cognitive behavioural therapy (CBT) with diabetes education. STEADY was previously tested in a feasibility randomised controlled trial (RCT), and the purpose of this work was to maximise trial learning to support future scaling up of STEADY in a multi‐site RCT.

This study addressed three research questions: (1) Which STEADY toolkit tools were used in the intervention, and at which point? (2) To what extent was treatment delivered as intended, reflecting the minimum competency (≥3) on the Cognitive Therapy Rating Scale (Revised; CTS‐R)? (3) How long did it take to deliver the STEADY intervention?

A range of STEADY tools were used during the trial; the five most frequent tools were CBT formulation (72 uses), behavioural experiments (47 uses), thought records (43 uses), goal setting (40 uses) and understanding emotions and ‘riding the wave’ (40 uses). The CTS‐R mean score was 3.81 ± 0.74, indicating competent adherence to CBT. Mean time to completion was 153.3 days (SD = 73).

When scaling up for a multi‐site RCT, some participants may need greater flexibility regarding timing to access all STEADY sessions. STEADY can be personalised through its toolkit‐based approach, and therapists should be mindful and trained in the range of tools available.

## Linked entities

- **Diseases:** Type 1 diabetes (MONDO:0005147)

## Full-text entities

- **Genes:** TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}
- **Diseases:** Eating Disorders (MESH:D001068), T1DE (MESH:D000080887), diabetes (MESH:D003920), Type 1 diabetes (MESH:D003922)
- **Chemicals:** Cognitive (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12535373/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12535373/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12535373/full.md

---
Source: https://tomesphere.com/paper/PMC12535373